Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1947 1
1949 1
1951 1
1955 2
1956 2
1957 1
1958 1
1961 1
1962 3
1963 1
1968 1
1970 2
1971 1
1974 3
1975 3
1976 2
1977 1
1978 1
1985 1
1988 2
1990 2
1993 1
1995 1
2000 1
2002 2
2003 2
2004 2
2005 3
2007 1
2008 3
2009 5
2010 2
2011 7
2012 3
2013 4
2014 4
2015 9
2016 4
2017 6
2018 6
2019 7
2020 8
2021 10
2022 11
2023 11
2024 13
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

158 results

Results by year

Filters applied: . Clear all
Page 1
Inhaled Fluticasone Furoate for Outpatient Treatment of Covid-19.
Boulware DR, Lindsell CJ, Stewart TG, Hernandez AF, Collins S, McCarthy MW, Jayaweera D, Gentile N, Castro M, Sulkowski M, McTigue K, Felker GM, Ginde AA, Dunsmore SE, Adam SJ, DeLong A, Hanna G, Remaly A, Thicklin F, Wilder R, Wilson S, Shenkman E, Naggie S; ACTIV-6 Study Group and Investigators. Boulware DR, et al. N Engl J Med. 2023 Sep 21;389(12):1085-1095. doi: 10.1056/NEJMoa2209421. N Engl J Med. 2023. PMID: 37733308 Free PMC article. Clinical Trial.
Updates on Common Mononeuropathies.
Cornejo A, Vo ML. Cornejo A, et al. Semin Neurol. 2025 Feb;45(1):13-23. doi: 10.1055/s-0044-1791578. Epub 2024 Oct 11. Semin Neurol. 2025. PMID: 39393796 Review.
Time to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo: The ACTIV-6 Randomized Clinical Trial.
Rothman RL, Stewart TG, Mourad A, Boulware DR, McCarthy MW, Thicklin F, Garcia Del Sol IT, Garcia JL, Bramante CT, Shah NS, Singh U, Williamson JC, Rebolledo PA, Jagannathan P, Schwasinger-Schmidt T, Ginde AA, Castro M, Jayaweera D, Sulkowski M, Gentile N, McTigue K, Felker GM, DeLong A, Wilder R, Collins S, Dunsmore SE, Adam SJ, Hanna GJ, Shenkman E, Hernandez AF, Naggie S, Lindsell CJ; Accelerating COVID-19 Therapeutic Interventions and Vaccines–6 Study Group and Investigators. Rothman RL, et al. JAMA Netw Open. 2024 Oct 1;7(10):e2439332. doi: 10.1001/jamanetworkopen.2024.39332. JAMA Netw Open. 2024. PMID: 39422912 Free PMC article. Clinical Trial.
Post-COVID-19 persistent headache: A multicentric 9-months follow-up study of 905 patients.
Garcia-Azorin D, Layos-Romero A, Porta-Etessam J, Membrilla JA, Caronna E, Gonzalez-Martinez A, Mencia ÁS, Segura T, Gonzalez-García N, Díaz-de-Terán J, Gallardo VJ, Gago-Veiga AB, Ballvé A, Trigo López J, Sastre-Real M, Llauradó A, Cornejo A, de Lorenzo Í, Guerrero-Peral Á, Pozo-Rosich P. Garcia-Azorin D, et al. Among authors: cornejo a. Cephalalgia. 2022 Jul;42(8):804-809. doi: 10.1177/03331024211068074. Epub 2022 Feb 15. Cephalalgia. 2022. PMID: 35166156
A new oxidative pathway of nitric oxide production from oximes in plants.
López-Gómez P, Buezo J, Urra M, Cornejo A, Esteban R, Fernández de Los Reyes J, Urarte E, Rodríguez-Dobreva E, Chamizo-Ampudia A, Eguaras A, Wolf S, Marino D, Martínez-Merino V, Moran JF. López-Gómez P, et al. Among authors: cornejo a. Mol Plant. 2024 Jan 1;17(1):178-198. doi: 10.1016/j.molp.2023.12.009. Epub 2023 Dec 15. Mol Plant. 2024. PMID: 38102832 Free article.
The Cytotoxic Effect of α-Synuclein Aggregates.
Melo F, Caballero L, Zamorano E, Ventura N, Navarro C, Doll I, Zamorano P, Cornejo A. Melo F, et al. Among authors: cornejo a. Chemphyschem. 2021 Mar 17;22(6):526-532. doi: 10.1002/cphc.202000831. Epub 2021 Feb 16. Chemphyschem. 2021. PMID: 33482036
Tryptophan Levels as a Marker of Auxins and Nitric Oxide Signaling.
López-Gómez P, Smith EN, Bota P, Cornejo A, Urra M, Buezo J, Moran JF. López-Gómez P, et al. Among authors: cornejo a. Plants (Basel). 2022 May 13;11(10):1304. doi: 10.3390/plants11101304. Plants (Basel). 2022. PMID: 35631729 Free PMC article.
Differences and similarities between COVID-19 related-headache and COVID-19 vaccine related-headache. A case-control study.
González-Celestino A, González-Osorio Y, García-Iglesias C, Echavarría-Iñiguez A, Sierra-Mencía A, Recio-García A, Trigo-López J, Planchuelo-Gómez A, Hurtado ML, Sierra-Martínez L, Ruiz M, Rojas-Hernández M, Pérez-Almendro C, Paniagua M, Núñez G, Mora M, Montilla C, Martínez-Badillo C, Lozano AG, Gil A, Cubero M, Cornejo A, Calcerrada I, Blanco M, Alberdí-Iglesias A, Fernández-de-Las-Peñas C, Guerrero-Peral AL, García-Azorín D. González-Celestino A, et al. Among authors: cornejo a. Rev Neurol. 2023 Nov 16;77(10):229-239. doi: 10.33588/rn.7710.2023063. Rev Neurol. 2023. PMID: 37962534 Free PMC article. English, Spanish.
Higher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With COVID-19: The ACTIV-6 Randomized Clinical Trial.
Stewart TG, Rebolledo PA, Mourad A, Lindsell CJ, Boulware DR, McCarthy MW, Thicklin F, Garcia Del Sol IT, Bramante CT, Lenert LA, Lim S, Williamson JC, Cardona OQ, Scott J, Schwasinger-Schmidt T, Ginde AA, Castro M, Jayaweera D, Sulkowski M, Gentile N, McTigue K, Felker GM, DeLong A, Wilder R, Rothman RL, Collins S, Dunsmore SE, Adam SJ, Hanna GJ, Shenkman E, Hernandez AF, Naggie S; Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)-6 Study Group and Investigators. Stewart TG, et al. JAMA. 2023 Dec 26;330(24):2354-2363. doi: 10.1001/jama.2023.23363. JAMA. 2023. PMID: 37976072 Free PMC article.
158 results